Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Globe Newswire•11/08/2026•07:01 ET
0
Whiz Insights
~ 2026 Second Quarter Net Product Sales of $17.1 Million, Up 78% Year over Year ~
~ 2026 Second Quarter Non-GAAP Adjusted EBITDA of $2.8 Million ~
Get started
Create a free account to read the full story.